The prevalence of MASLD (metabolic dysfunction-associated steatotic liver disease) is exploding in most regions of the world, boosted by increased obesity and sedentary lifestyles. MASLD (formerly known as non-alcoholic fatty ...
6 hours ago
0
13
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.
Nov 26, 2024
0
0
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a key biological reason why obesity increases the risk of type 2 diabetes, and it boils down to size—specifically ...
Nov 22, 2024
0
17
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns. Fortunately, this attention to cholesterol ...
Nov 14, 2024
0
39
UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than 40 million people. The ...
Nov 13, 2024
0
21
Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.
Nov 13, 2024
0
0
Over the last 20 years, vast advancements in the field of biotechnology have led to the development of a research approach called multi-omics, which looks at multiple layers of biological information—like gene expression, ...
Nov 12, 2024
0
0
Scientists at deCODE genetics have published a study in Nature Communications that sheds light on how body mass index (BMI) influences the risk of various diseases that are comorbid with obesity. The study, which used genetic ...
Nov 12, 2024
0
10
Chronic viral hepatitis is the long-term inflammation of the liver. It is caused by hepatitis B, C or D virus particles. Even though these viruses replicate differently, they all use the endoplasmic reticulum-Golgi pathway ...
Nov 4, 2024
0
0
A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1—the most prevalent form of adult-onset muscular dystrophy—provides insight into why patients develop fatty liver disease and display hypersensitivity ...
Oct 24, 2024
0
41
